None listed
Conditions
Brief summary
The study comprises a randomised trial of intensive “wrap around” management versus standard guideline-based care. Sixty (60) patients with type 2 diabetes and morbid obesity (BMI = 35) will be enrolled. Patients will attend on average nine (9) scheduled study visits over the course of the study. Those found to be eligible after the baseline assessments will be randomised to receive a “wrap around” regimen comprising intensive psychological assessment/counselling, cultural support, intensive dietetic assessment/counselling and an exercise programme or standard guideline-based care in a 1:1 ratio. All participants (i.e. intensive management and standard care) will undergo a bariatric surgery procedure 6-months after randomisation. The total duration of follow-up is 18 months.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Type 2 diabetes Morbid Obesity - BMI >35
Exclusion criteria
Diabetic nephropathy. A significant malabsorptive or gastrointestinal disorder.